News | August 27, 2021

Meet Kevin: Newterra's New CEO


Newterra is proud to announce the appointment of KEVIN CASSIDY as our new CEO. Newterra is a leading water and wastewater technology company backed by Frontenac, a Chicago based private equity firm.

Jim McGivern, Newterra’s Chairman of the Board, said "I am very excited to welcome Kevin to our team as the new CEO. Kevin has a track record of growing water and wastewater technology businesses, is a strong and ethical leader and has the experience that will enable continued strong growth at Newterra."

Kevin has spent more than 30 years working for GE and Suez in a variety of senior roles. The majority of his experience has been in the water and wastewater industry. Kevin is joining Newterra after successfully leading the Engineered Solutions business of Suez, one of the premier service providers in our industry, for the last 4 years.

Kevin also brings a global perspective, having held a number of global roles throughout his career including 6 years in Asia with his family leading GE’s Asia water business. Kevin said “It is an absolute honor to have been chosen by the Board of Directors to write the next chapter of Newterra’s growth. I inherited a strong management team with an excellent reputation in the market for exceptional products and service. These will be important building blocks as we look to develop new and innovative ways to service our customers.”

About Newterra

Newterra is a leader in designing, engineering, manufacturing, and servicing Modular Treatment Solutions for water, wastewater, and groundwater. Newterra’s comprehensive portfolio of brands include Cochrane, TIGG, Aeration Industries, StormwateRx, EPRO and of course Newterra. The Company’s customers include Private Developers, Industries, Institutions, Municipalities, EPC firms, Government entities, Food and Beverage companies, Remediation consultants and contractors and Aquaculture companies. Newterra provides technologies that include Deaerators, Membrane Filtration such as RO and UF, Modular Membrane Bioreactors (MBR) and Potable Water Systems, Sequential Batch Reactors (SBR), Surface Aeration Products, Stormwater treatment, Chemical Treatment systems, and a host of Remediation Technologies including products related to PFAS and emerging contaminants removal. For more information, visit

About Frontenac

Frontenac is a Chicago-based private equity firm. The firm focuses on investing in lower middle market buyout transactions in the consumer, industrial, and services industries. Frontenac works in partnership with established operating leaders, through an executivecentric approach called CEO1ST, which seeks to identify, acquire, and build market-leading companies through transformational acquisitions and operational excellence. Over the last 50 years, Frontenac has built a leading franchise working with over 275 owners of mid-sized businesses as they address complex transition issues of liquidity, management enhancement, and growth planning. For more information, visit